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Introduction. Yellow fever is an infectious disease endemic in Africa and South America, and it is a vaccine-13 
preventable disease. The outbreak of yellow fever in Angola, 2015-2016 posed a risk to the global health. 14 
In the early phase of the outbreak, mathematical modeling can be a useful tool to predicting how the 15 
outbreak might spread and what factors affect the course of the outbreak so that health policy makers 16 
and health organizations can react effectively. In this project, two mathematical models, generalized-17 
growth model and generalized Richard model, were applied retrospectively to predict the case rises in the 18 
early phase and to forecast the short-term trend of the outbreak. 19 
 20 
Data and method. The data was extracted from the WHO weekly outbreak situation reports, for the 21 
period from Dec 04, 2015 until Sep 29, 2016. The analysis was focused on the data of 3 provinces including 22 
the capital Luanda, Huambo, and Benguela. The generalized-growth model (GGM) was applied for fitting 23 
the model into the early phase of the outbreak. GGM and the generalized Richards model (GRM) was 24 
applied for short-term forecasting the trend of the outbreak’s peak. Simulations to project the uncertainty 25 
of the epidemic trend was conducted with MATLAB R2017a (The Mathworks, Inc.). 26 
 27 
Results. Fitting GGM to the data of 3 provinces shows the patterns of case rises in the early phase widely 28 
vary from above-constant to sub-exponentially growth. Short-term forecasting with GGM becomes less 29 
capable after the epidemic reach its peak. GRM is more advantageous for the forecasting period 30 
containing the epidemic peak. However, it can be less effective when the outbreak is partly controlled or 31 
there are some interventions on the epidemic transmission.  32 
 33 
Conclusion. GGM and GRM can be the useful tool to characterize the dynamic growth of an infectious 34 
outbreak in the early phase and produce a short-term forecast of dynamic patterns that shape the 35 
guidance and action for the outbreak control and interventions. 36 
 37 
Key words: Angola, Yellow Fever, generalized-growth model, GGM, generalized Richards model, GRM, 38 
phenomenological modeling. 39 
 40 
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INTRODUCTION AND BACKGROUND 209 
Yellow fever. Yellow fever is a mosquito-borne zoonotic disease, transmitted through the bite of the 210 
infected mosquitoes, Aedes or Haemagogus species, as the vector. The disease is endemic and 211 
intermittently epidemic in many countries in Africa and Central and South Americas. 2015-16 witnesses 212 
the worst yellow fever outbreak in Angola in the last three decades, resulted in 4,347 notified cases and 213 
more than 377 deaths, reported until the end of September 2016 (1). The disease was spread to the 214 
Democratic Republic of the Congo, and imported cases from Angola were reported in Kenya, China, and 215 
Brazil. In 2017 the disease has been emerging in South Africa, and some countries have cases notified, 216 
including Brazil, Bolivia, Peru, Columbia and Ecuador. 217 
 218 
The pathogen. Yellow fever virus (YFV) is an Arborvirus that belongs to the family Flaviviridae, and related 219 
to dengue virus, Zika virus, West Nile virus, and tick-born encephalitis virus. The spread of YFV occurs 220 
through three transmission cycles: in the jungle (sylvatic) cycle, the infection is transmitted among non-221 
human primates and to human by different mosquitoes, and in the intermediate (savannah) and urban 222 
cycle, yellow fever is transmitted from an infected human to a susceptible on by Aedes Aegypti bites. 223 
Although savannah transmission is more dominant in Africa, it is expected to shift to urban yellow fever 224 
if the environment becomes more facilitating for mosquitos flourishment and the population immunity is 225 
vulnerable (2). In 2016 Angola outbreak, the cases were found mainly in cities, suggesting that the 226 
transmission occur through urban cycle. The transmission dynamic of YFV is associated with climatic 227 
conditions. Infection occurrence is most common during the months of heavy rainfall and high 228 
temperature. While high temperature is supposed to facilitate the survival and reproduction rate and 229 
shorten extrinsic incubation period in mosquitoes, increased precipitation might expand the existing larval 230 
habitats and create new breeding grounds. 231 
 232 
Clinical manifestation. In human, most of cases are asymptomatic, however if the symptoms occur after 233 
the 3-6-day incubation period, the progress is typically through 3 phases. The first phase (acute phase) 234 
can last for 3-4 days, characterized by non-specific, flu-like generalized symptoms such as fever and chills, 235 
loss of appetite, headache, muscle aches, nausea, vomiting. The second phase (remission) lasts for 48 236 
hours when the symptoms relieve, and most of patients recover. After the second phase, approximately 237 
10-15% patients develop to the third phase (toxic phase) (3). In the toxic phase, the acute hemorrhagic 238 
syndrome appears, with manifestations of high fever, internal bleeding, damage of liver, kidney, and 239 
circulation system, shock, and multiple organ failure. Death is estimated 25-50% of those progressing to 240 
this phase (3)(4) . In the 2015-16 outbreak, the death rate among confirmed cases is high, nearly 14% 241 
(121/884) (1). 242 
 243 
Epidemiology. Yellow fever is one of major public health issues in Africa, and most of the cases in the 244 
world have been reported in Africa. In Africa, while the endemic area spreads from the South edge of 245 
Sahara Desert in the North to Angola in the south, there have been more cases reported in the West 246 
countries. Most of the outbreaks and the large outbreaks of YF also occurred in the West countries. Over 247 
70 years before the outbreak in Angola (the South Africa) in 2015, there were 2 major peaks of YF reported 248 
in Africa. The early peak was in 1960-1962, mainly due to the outbreak in Ethiopia (the East Africa), and 249 
the later in 1985-1995, mainly due to the outbreak in Nigeria (the West Africa) (5).  250 
 251 
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 252 
YF is one of diseases required to report to WHO. However, the actual number of cases is suspected to be 253 
10-500 times higher than the reported number. The underestimated burden of FY is due to the limitation 254 
of surveillance and healthcare system of the affected countries (6). In additional, there is a challenge in 255 
differentiating FY from other hemorrhagic fevers prevalent in the endemic regions. A previous WHO 256 
estimation based on data source from 1990s reported that the annual number of cases and death of YF in 257 
Africa were 200,000 and 30,000 respectively (3)(6)(7). Recently, a modeling study using data of yellow 258 
fever cases reported in Africa for 25 years, 1987-2011, provided an estimation with a high level of 259 
uncertainty that there were annually 130,000 cases including 78,000 deaths (8). In Angola, before the 260 
2015-16 outbreak, there were two small outbreaks over one hundred years. One was in 1971 with 65 261 
cases and 41 deaths, and one was in 1988 with 37 cases and 14 deaths. Then there was no any cases 262 
reported in Angola over 27 recent years (2)(9).   263 
 264 
Vaccination and population immunity. Vaccination is the single key measure for yellow fever prevention. 265 
The vaccination for yellow fever is 17D, an attenuated live vaccine that has remained a safe and highly 266 
efficacious vaccine over 60 years. A single dose of vaccination provides immune protection after 7-10 days 267 
in 95% of people vaccinated, and in 99% after 1 month (6). The protection lasts for at least 10 years. Some 268 
studies showed that it can provide protection for many years or even for a whole life (3)(10). In resource-269 
limited settings, a single dose is acknowledged of a long-life protection. Due to the shortage of vaccination 270 
stockpile in the Angola 2015-16 outbreak, a smaller dose or fractional dose of vaccine (a fifth of standard 271 
dose) was applied as a short-term measure in the emergency setting. A single fractional dose of 272 
vaccination can provide the protection for at least 12 months (11) .  273 
 274 
Preventive vaccination campaigns can help to reduce cases and death up to 27% in areas covered by these 275 
campaigns (8). To prevent outbreaks, vaccination coverage should reach 60%-80% of the target 276 
population (7). However, there were few countries in Africa reporting to reach this coverage. By the end 277 
of 2006, it is estimated that only a half of high-risk countries in Africa achieved vaccination coverage of 278 
80%, while the situation was better in South America, the coverage rate was obtained at more than 80% 279 
in 10 endemic countries (3). 280 
 281 
Foreseen global threat after increases of YF reports in West Africa and South America led to activities of 282 
The Yellow Fever Initiative launched in 2006. This aimed to reduce to global risk of yellow fever outbreaks 283 
through ensuring the global vaccine supply and increasing the population immunity in high-risk areas (7). 284 
According to that, routine childhood vaccination and preventive vaccination campaigns were 285 
implemented in high-risk countries defined by the Yellow Fever Initiative, mostly in West Africa and South 286 
America. After implementing YF Initiative, the routine vaccination coverage of the targeted high-risk 287 
population significantly increased, from 16% (2000) to 43% (2008) in Africa; and from 64% to 91% in South 288 
America (7). Before the 2015-16 outbreak, Angola and DRC were not classified as in high-risk areas and 289 
preventive vaccine campaign was not implemented through The YF Initiative. The estimated vaccine 290 
coverage in the country increased over the last decade from 29% (2000) to 64% (2013) but still not reach 291 
the level to prevent an outbreak (9). After the outbreak, both Angola and DRC were benefited from 292 
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massive vaccination campaign. However, the preventive campaign is still in high demand in some other 293 
high-risk countries in Africa and South America. 294 
 295 
The 2015-16 yellow fever outbreak in Angola. The outbreak of yellow fever in Angola started in the first 296 
week of Dec 2015  among Eritrean and Congolese citizens in Viana municipality, a suburb by 20 km to the 297 
East of the capital Luanda (12). The place was an area with a high density of Aedes Aegypti, the primary 298 
vector for yellow fever transmission. The index case was notified in early of Dec 2015, and confirmed later 299 
outside Angola with the PCR test at the Zoonosis and Emerging Disease Laboratory of the National 300 
Institute for Communicable Diseases in Johannesburg, South Africa and at the Pasteur Institute in Dakar, 301 
Senegal.  302 
By January 2016, four weeks after detecting the index case, WHO was notified of the potential outbreak 303 
of yellow fever in Angola. By this time, there were 23 cases confirmed, and the rapid increase of infected 304 
cases was anticipated. There were quick responses from the public health authorities in Angola and WHO 305 
to contain the outbreak, including outbreak response coordination, clinical case management, enhanced 306 
laboratory testing and surveillance, social mobilization and vector control measurements, and financial 307 
support. The outbreak of YF in Angola also spread to the neighbor country of DR Congo after a sport event 308 
of football between two countries, and YF imported cases were also notified in China and Kenya. By April 309 
2016, four months after starting of the outbreak, WHO declared the YF outbreak in Angola as a global 310 
threat. The capital Luanda was the province with the highest confirmed cases. The following provinces 311 
were Huambo and Benguela where the first notified cases there occurred in 6-7 weeks after the index 312 
case in Luanda. 313 
In Luanda, by early of February, 8 weeks after the index case, the massive vaccination campaign was 314 
initially implemented. By early of March, 4 weeks later, the vaccination coverage reached nearly 80% of 315 
Luanda target, and the trend of incidence cases in Luanda dramatically decreased. By this time, 9 out of 316 
15 provinces in Angola reported confirmed cases, and the yellow fever still spread to other provinces. In 317 
Huambo and Benguela, by the middle of April, EW19 of the outbreak, the massive vaccination was 318 
implemented., 319 
After May, Luanda completed its massive vaccination. The vaccination in Huambo and Benguela also 320 
reached 80% of their target population, and there were just a few new cases reported in those provinces 321 
after then. The estimated total population in Angola in 2015 was approximately 28 million people (13). By 322 
the end of July, the population vaccinated in Angola was about more than 13 million people, 86% of target 323 
population (14). By the end of September 2016, 16 million people were vaccinated. By early October 2016, 324 
two more million people were vaccinated to reach the vaccine coverage of 18 million people. 325 
According to WHO final situation reports, during ten months from Dec 2015 to Oct 2016 in Angola, there 326 
were more than 4300 suspected cases, 880 confirmed cases, and 370 deaths. Suspected cases were found 327 
in all 18 provinces, and confirmed cases found in 16 out 18 provinces of Angola.  328 
Table 1: Some key relevant events throughout the outbreak 329 
Calendar timeline Epidemic week (EW0-
EW43) 
Events 
December 05, 2015 EW0 Index case notified in the capital Luanda, 
Angola 
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Early of January, 2016 EW6 The first case notified in Huambo 
Middle of January, 2016 EW7 The first case notified in Benguela 
Early of February, 2016 EW9 Massive vaccination implemented, starting 
first in Luanda 
Middle of March, 2016 EW14 The first WHO situation report was 
available. 
End of March, 2016 EW15 Massive vaccination covered more than 80% 
target population in Luanda 
Middle of April, 2016 EW19 Massive vaccination implemented in the 
provinces of Huambo and Benguela 
End of May, 2016 EW25 Massive vaccination reached 80% of the 
target population in Huambo and Benguela.   
September 29, 2016 EW43 The outbreak ends 
 330 
Study rationale. The control of yellow fever outbreak required the collaboration from different 331 
stakeholders including the local health authorities, emergency response from international organizations, 332 
vaccination providers, environment and vector control agencies, health education, health policy makers, 333 
etc. In the early period of the outbreak, mathematical modeling can be a helpful method in predicting of 334 
how the outbreak might spread and what factors affecting the course of the outbreak so that health 335 
policymakers and relevant organizations can provide appropriate responses. In this project, two 336 
mathematical models, generalized-growth model and generalized Richard model, were applied 337 
retrospectively to predict the spread of the outbreak in the early phase and to forecast the short-term 338 
trend of the outbreak after the peak.  339 
DATA AND METHODS 340 
The epidemiological data was extracted from the WHO outbreak situation reports available on the open-341 
accessed WHO website, for the period from Dec 04, 2015 until Oct 28, 2016 (1). The reports include 342 
confirmed and probable cases weekly in each province, target population and dose of vaccination 343 
administered weekly in each province. The analysis was focused on data of 3 provinces, the capital Luanda, 344 
Huambo, and Benguela that are the three highest-case provinces in Angola. We assumed that the data 345 
from those provinces probably be presentative for the data of the whole Angola (Graph 1). The data of 346 
vaccination coverage were also considered. The number of target population for Huambo and Benguela 347 
slightly altered during the massive vaccination campaign. To have another comparison of the vaccination 348 
situation, the percentage of vaccinated population was estimated base on the number of vaccine doses 349 
administered extracted from the situation reports and the population of each province collected from the 350 
record of Angola population in 2016 (15). In the context of the limited-resource setting of the Angola, the 351 
cases include probable and confirmed cases to avoid underestimating the extent of the outbreak. 352 
  353 
The exponential growth model can be applied to predict the pattern of case rise in the early period of an 354 
epidemic. This model basically assumes that the cumulative number of cases (probable and confirmed) 355 
has an exponential growth in the early phase. The cumulative number of cases is described by the 356 
exponential equation: C(t)= C(0)r*t, where C (t) is the cumulative number of cases at the time t, C(0) is the 357 
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number at the beginning of the outbreak, r is the growth rate of cases per unit of time (day). This equation 358 
is solved by the differential equation: C’(t) = dC/dt = r*C(t) for the exponential growth model.   359 
 360 
When this assumption is not fully satisfied, the early pattern of case rise becomes sub-exponential growth 361 
rather than truly exponential growth. The generalized-growth model (GGM) is considered in such settings. 362 
This model is given by the differential equation: dC(t)/dt = C’(t)=r*C(t)p, where p is the parameter of 363 
“deceleration of growth” with the values ranging between 0 and 1. When the incidence of cases increases 364 
exponentially, the assumption is fully satisfied, p reaches to 1, and the pattern shows an exponential 365 
growth. When the incidence of cases keeps constant, p reaches to 0, and the pattern shows a horizontal 366 
line. When p is in the middle of the range (0,1), the pattern shows a sub-exponential growth. This model 367 
GGM was demonstrated useful in forecasting infectious outbreaks, including Ebola and food and mouth 368 
disease (16).  369 
 370 
The generalized Richard model (GRM) is given by the differential equation C’(t)=r*Cp(1-(C/K))ɑ, , where p 371 
is the deceleration of growth, ranging from 0 to 1, r is the intrinsic growth rate, K is the epidemic size, and 372 
ɑ is the parameter modulating the timing of the pandemic peak. This model is applied to fit to an S-shaped 373 
growth curve that allows the early curve to change in a wide range of sub-exponential growth, with 0<p<1. 374 
This model was also used in forecasting the Ebola outbreak (17).  375 
 376 
In this project, GGM was used to fit into the data of early few weeks of each province, and GRM was 377 
applied in forecasting a short-term period of 4 weeks. The parameter r and p were estimated using the 378 
nonlinear least-square fitting method by fitting the observed cumulative number of cases into the curve 379 
modeled by C’(t) of GGM in the early weeks of the outbreak. The numbers of confirmed and probable YF 380 
cases available in weeks were switched into the numbers of cases in days. The initial numbers of cases 381 
based on the initial observed numbers of cases for each province (2 in Luanda, 1 in Huambo and Benguela). 382 
The 95% confidence intervals of estimated parameters were calculated based on simulating 200 383 
realizations of the best-fit curve of the model.  384 
 385 
The period of early phases of 3 provinces was subjectively considered as the period before the massive 386 
campaign, the key measure of control for the outbreak, implemented. In Luanda, the early phase was the 387 
period from the epidemic week (EW) 0 (the week of index case found) to the epidemic week 9. The period 388 
of early phases in Huambo and Benguela were the EW 6 – 19 and EW 7 – 19, the early 12 and 13 weeks 389 
from the first local cases found in Huambo and Benguela until the vaccination campaign started in each 390 
province, respectively.  391 
RESULTS 392 
Applying GGM fitting the model in early phase of the outbreak 393 
When applying GGM fitting in early phase for the data for each province and 3 provinces combined, the 394 
growth of case rises varies widely from nearly constant to exponentially (Figure 1 and 2).  For Luanda, the 395 
visualization of growth shows more exponentially fitted in 9 weeks than in 7 weeks. The p values shift 396 
towards 1, and the 95% confidence intervals of p values narrow down and include 1. For 7 weeks, p = 397 
0.912 (0.590, 1.000) and for 9 weeks, p = 0.965 (0.839, 1.000) (Table 2). For Huambo, the case rise shows 398 
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a linear growth in 7 weeks and 9 weeks with p values around 0.5, p = 0.451 (0.157, 0.782), and p = 0.402 399 
(0.166, 0.650), respectively. In Benguela, the growth shows a slightly linear rise in early 7 weeks. However, 400 
the rise moves close to the constant growth in the data of 9 weeks, p values decreases toward 0 and with 401 
a large uncertainty, p = 0.270 (0.000, 1.000).  402 
Table 2. Estimated parameters for r and p in GGM: 403 
 For early 7 weeks For early 9 weeks 
r (95%CI) p (95%CI) r (95%CI) p (95%CI) 
Luanda 0.089 (0.062, 0.204) 0.912 (0.590, 1.000) 0.082(0.070, 0.121) 0.965 (0.839, 1.000) 
Huambo 0.457 (0.154, 0.940) 0.451 (0.157, 0.782) 0.500 (0.200, 1.162) 0.402 (0.166, 0.650) 
Benguela 0.239 (0.063, 0.552) 0.398 (0.000, 1.000) 0.274 (0.051, 0.571) 0.270 (0.000, 1.000) 
3 Provinces 0.092 (0.064, 0.187) 0.917 (0.638, 1.000) 0.084 (0.073, 0.122) 0.970 (0.850, 1.000) 
 404 
Applying GRM forecasting the short-term period of the outbreak 405 
For Luanda, the trajectory area can capture fairly the trend of the observed data. When the epidemic peak 406 
falls in the forecasting period, there is a shift of the observed trend from the upper limit of the uncertainty 407 
estimation area before the peak to the lower limit of the uncertainty estimation area after the peak. 408 
(Figure 5). For Huambo, GRM captures more faithfully the trend of the pandemic. For Benguela, GRM 409 
predicts well in early weeks. However, in later weeks (week 9 and 10), GRM fails to capture the second 410 
peak of the case rise when the case rise moves up abruptly  411 
DISCUSSION  412 
Luanda was the place where the outbreak started before spreading to other provinces. The number of 413 
cases in Luanda (confirmed and probable) constitutes a significant portion of the total cases in Angola. 414 
Therefore, the trend of case rise of Luanda closely describes the trend of case rise of the combined three 415 
provinces and of the whole Angola (Graph 1). For Luanda data and 3 provinces data combined, applying 416 
the GGM and GRM, to fit the observed data into the model and forecasting short-term period, it exhibited 417 
analogous trends and forecasting trajectories.  418 
  419 
The GGM can be considered as a useful method to described the case rise in the early phase of infectious 420 
outbreaks (16). In this project, the results of fitting observed data of each province and 3 provinces 421 
combined to the GGM again demonstrated this capacity of the model. The model can fit into the case 422 
rises varying from above-constant growth to closely exponential growth. In Luanda, the growth pattern 423 
of the first 9 weeks (EW0-EW9) is very close to exponential growth, p=0.965 (0.839, 1.000). This 424 
phenomenon is consistent with a high reproductive number of yellow fever. The basic reproductive 425 
number of the disease was estimated to vary from 1.7 to 3.6 (18), and in a recent study also using the data 426 
of this outbreak, the reproductive number was estimated up to 4.8 (4.0, 5.6) (19). The high case rise in 427 
Luanda was also because the outbreak occurred initially there when the effective measures to control the 428 
disease were not fully established in this early period. Massive vaccination campaign started in Luanda in 429 
EW9, and 2 weeks later, the epidemiological curve of incidences in Luanda reached its plateau in EW10-430 
11 (Graph 2).  431 
  432 
However, GGM can be more useful to project the rise trend in the primary outbreak location rather than 433 
in secondary outbreak location. In Huambo and Benguela, the trends in early phase were not typical or 434 
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closely exponential growth. The epidemics in those sites occurred in EW6-7, when emergency responses 435 
might already have some effects on containing the transmission, particularly the vaccination coverage in 436 
Luanda attained 80% in just few weeks after being implemented. It is consistent for the data of 3 provinces 437 
that the incidence curves run down when the curves of vaccination coverage go up (Graph 2,3,4).  438 
In Benguela, the early pattern of case rise shows an above-constant growth, with a wide range of 439 
uncertainty estimation containing the 0 and 1 value of p, p=0.398 (0.000, 1.000), for early 7 weeks, and 440 
p=0.270 (0.000, 1.000) for early 9 weeks. This conforms to that the epidemiologic curve of incidences in 441 
Benguela fluctuate in the early weeks (EW7-EW17) and increase dramatically later by (EW18-21). When 442 
applying GGM for the longer epidemic period covering the epidemic peak of Benguela, the trajectory 443 
pattern changes to sub-exponential growth with a narrower uncertainty estimation of p value, p = 0.871 444 
(0.634, 1.000) (Figure 3). 445 
GGM can be helpful in forecasting in the very early phase of the epidemic. However, after the epidemic 446 
reaches to its peak, GGM becomes less capable to capture the decreasing patterns into its trajectories 447 
(Figure 4). GRM showed to be more advantageous than GGM in forecasting the short-term periods 448 
including the peak of epidemic. However, in case of the fluctuating early phase of Benguela, GRM misses 449 
the real peak of the pandemic (Figure 5). It should be cautious to apply GRM to predict the case rise when 450 
the outbreak is partly controlled or in secondary pandemic sites.   451 
The challenge is how those mathematical models can work as a useful tool in practice, particularly from 452 
the beginning of outbreaks to support the control of infectious outbreaks. In this project, with those 453 
mathematical models applied retrospectively and the main intervention of the outbreak already known, 454 
the uncertainty of the model can be easily assessed.  In term of practical utility, a large uncertainty of 455 
trends of case rise might be an disadvantage when applying the method for emergency responses.  456 
CONCLUSIONS 457 
The case rise of yellow fever in Angola in the first early weeks was characterized by a sub-exponential 458 
growth, ranging from the above-constant growth to the close-to-exponential growth. The case rise in the 459 
primary pandemic site before the outbreak was partially controlled is closely exponential growth. The 460 
intervention of implementing vaccination has significant influence on the trend of case rise.   461 
 462 
GGM is the useful tools to describe the dynamic growth of an infectious outbreak in the early phase, and 463 
GRM is helpful to produce a short-term forecast of pandemic trend.  It should be careful when applying 464 
GRM in case that the epidemic is influenced by some intervention effects or has a fluctuating early phase, 465 
GRM can fail to capture the real peak of the epidemic.  466 
 467 
It is vital to bringing mathematical modeling into practice during infectious dynamics that cases should be 468 
early notified, and the data should be more accessible to modeling epidemiologists. In settings with more 469 
available data and advanced data managing system, those phenomenological models can be integrated 470 
into strategies of emergency responses to predict the outbreak patterns that provide prompt guidance 471 
and shape actions for the outbreak control. 472 
   473 
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GRAPHS AND FIGURES 474 
Epidemiological Curve of Incidences (Confirmed and Probable) and vaccination in 3 provinces: Luanda, 475 
Huambo and Benguela 476 
Graph 1. Weekly Reported Cases in Angola and 3 provinces 477 
 478 
 479 
Graph 2: Luanda Vaccination (the vaccination started from EW9, however the data of vaccination 480 
coverage percentage available from EW16) 481 
 482 
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Graph 3: Huambo Vaccination 485 
 486 
 487 
Graph 4: Benguela Vaccination 488 
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Graph 5: Confirmed and Probable cases of 3 provinces and some key events 492 
 493 
 494 
  495 
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Figure 1. Fitted GGM in early phase of 7 weeks for Luanda, Huambo, Benguela and 3 provinces 496 
combined.  497 
 498 
 499 
Figure 2. Fitted GGM in early phase of 9 weeks for Luanda, Huambo, Benguela and 3 provinces 500 
combined. 501 
 502 
 503 
 504 
 505 
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Figure 3. Fitted GGM in early phase of 14 weeks for Benguela. 507 
 508 
 509 
  510 
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Figure 4. Forecasting with GGM  511 
 512 
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Figure 5. Forecasting with GRM  517 
 518 
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